GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCY) » Definitions » EPS without NRI

ANGLE (ANPCY) EPS without NRI : $-1.07 (TTM As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ANGLE EPS without NRI?

ANGLE's earnings per share without non-recurring items for the six months ended in Jun. 2023 was $-0.48. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.07.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -9.80% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for ANGLE's EPS without NRI or its related term are showing as below:

ANPCY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -81.7   Med: -0.8   Max: 16.1
Current: -9.8

During the past 13 years, ANGLE's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 16.10% per year. The lowest was -81.70% per year. And the median was -0.80% per year.

ANPCY's 3-Year EPS without NRI Growth Rate is ranked worse than
67.24% of 174 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.7 vs ANPCY: -9.80

ANGLE's EPS (Diluted) for the six months ended in Jun. 2023 was $-0.48. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.07.

ANGLE's EPS (Basic) for the six months ended in Jun. 2023 was $-0.48. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.07.


ANGLE EPS without NRI Historical Data

The historical data trend for ANGLE's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE EPS without NRI Chart

ANGLE Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.06 -0.81 -0.84 -0.86 -1.00

ANGLE Semi-Annual Data
Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 -0.41 -0.48 -0.59 -0.48

Competitive Comparison of ANGLE's EPS without NRI

For the Diagnostics & Research subindustry, ANGLE's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANGLE's PE Ratio without NRI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where ANGLE's PE Ratio without NRI falls into.



ANGLE EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANGLE  (OTCPK:ANPCY) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


ANGLE EPS without NRI Related Terms

Thank you for viewing the detailed overview of ANGLE's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


ANGLE (ANPCY) Business Description

Traded in Other Exchanges
Address
10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCY) Headlines

From GuruFocus

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire 04-12-2019

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE 04-30-2021

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE 07-08-2020